← Back to Search

Monoclonal Antibodies

Group II: Ustekinumab 45 mg for Psoriasis

Phase 3
Waitlist Available
Research Sponsored by Centocor Research & Development, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up week 40 to week 52
Awards & highlights

Summary

The primary objective of this study is to evaluate the efficacy and safety of ustekinumab (CNTO 1275) in the treatment of patients with moderate to severe plaque psoriasis.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~week 40 to week 52
This trial's timeline: 3 weeks for screening, Varies for treatment, and week 40 to week 52 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Number of Participants With Psoriasis Area and Severity Index (PASI) Score of 75 Percent or Above at Week 12
Secondary outcome measures
Change in Dermatology Life Quality Index (DLQI) at Week 12
Psoriasis
Number of Participants With Physician Global Assessment (PGA) of Cleared or Minimal at Week 12

Trial Design

3Treatment groups
Experimental Treatment
Placebo Group
Group I: Group III: Ustekinumab 90 mgExperimental Treatment1 Intervention
Group II: Group II: Ustekinumab 45 mgExperimental Treatment1 Intervention
Group III: Group I: PlaceboPlacebo Group1 Intervention
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Ustekinumab
FDA approved
Ustekinumab
FDA approved

Find a Location

Who is running the clinical trial?

Centocor Research & Development, Inc.Lead Sponsor
4 Previous Clinical Trials
907 Total Patients Enrolled
1 Trials studying Psoriasis
766 Patients Enrolled for Psoriasis
Centocor, Inc. Clinical TrialStudy DirectorCentocor, Inc.
72 Previous Clinical Trials
30,214 Total Patients Enrolled
10 Trials studying Psoriasis
6,086 Patients Enrolled for Psoriasis
~60 spots leftby Sep 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top